Results 81 to 90 of about 25,289 (245)

Ivabradine and Valsartan/sacubitril: Two Newly Approved Drugs in Cardiac Disorders

, 2018
Description of two newly approved drugs for use in cardiac failure. One of them being Ivabradine, the other one being the combination of valsartan/sacubitril.
Soleimanpor, Armin
core  

Simultaneous Determination of Amlodipine and Valsartan

, 2011
A spectrophotometric method was developed for simultaneous determination of amlodipine (Aml) and valsartan (Val) without previous separation. In this method amlodipine in methanolic solution was determined using zero order UV spectrophotometry by ...
Nashwah Gadallah Mohamed
core   +1 more source

Unterscheiden sich Nutzer von potenziell NDMA-kontaminierten Valsartan-Generika und Nutzer von Valsartan-Originalpräparaten in Deutschland hinsichtlich des sozioökonomischen Status?

, 2022
A recently published study from Germany suggested an increased risk of liver cancer among NDMA-contaminated generic valsartan users. However, studies from the US showed that generic versus brand-name drug users differ regarding socioeconomic ...
Haug, U, Schäfer, Wiebke, Haug, Ulrike, Schäfer, W, Platzbecker, Katharina, Platzbecker, K   +5 more
core   +1 more source

The Effects of Angiotensin Receptor Neprilysin Inhibitor on Endoplasmic Reticulum Stress in Doxorubicin‐Mediated Cardiomyopathy‐Associated Heart Failure Model in Rats

Journal of Applied Toxicology, EarlyView.
ABSTRACT One of the most serious complications associated with the use of the chemotherapeutic agent doxorubicin (DOX) is cardiomyopathy. Although cardioprotective drugs such as angiotensin receptor‐neprilysin inhibitors (ARNI) are used to prevent cardiomyopathy in DOX patients, no studies have reported the relationship between ARNI and endoplasmic ...
Mert Unvan, Meryem İlkay Karagül, Hatice Oruç Demirbağ, Ebru Balli   +3 more
wiley   +1 more source

Role of triple fixed combination valsartan, amlodipine and hydrochlorothiazide in controlling blood pressure

, 2010
Monica Doménech, Antonio CocaHypertension Unit, Department of Internal Medicine, Institute of Internal Medicine and Dermatology, Hospital Clinic (IDIBAPS), University of Barcelona, SpainAbstract: Hypertension is one of the main risk factors ...
Antonio Coca, Monica Doménech
core  

Removal of pharmaceuticals from municipal wastewater using a powdered activated carbon‐supplemented moving bed membrane bioreactor

Journal of Chemical Technology &Biotechnology, EarlyView.
Abstract BACKGROUND The new European Union Wastewater Directive 2024/3019 requires upgrading sewage treatment plants to achieve 80% removal of micropollutants. This study aimed to compare different Powdered Activated Carbon dosing strategies within a hybrid Moving Bed‐Membrane Bioreactor (PAC‐MB‐MBR) system, to evaluate its performance and to study the
Athanasia Iliopoulou, Petros Mastoras, Georgia Gatidou, Kallisti Skarveli, Konstantina Adamaki, Olga S Arvaniti, Maria Aloupi, Michail S Fountoulakis, Athanasios S Stasinakis   +8 more
wiley   +1 more source

A real-world pharmacovigilance analysis of potential ototoxicity associated with sacubitril/valsartan based on FDA Adverse Event Reporting System (FAERS)

Scientific Reports
Sacubitril/valsartan, a first-in-class angiotensin receptor neprilysin inhibitor, is widely used to treat heart failure. Despite its efficacy, sacubitril/valsartan inevitably causes adverse events such as hypotension, renal dysfunction, hyperkalemia, and
Ning Wang, Haijun Wang, Ying Chen, Yanfeng Wang   +3 more
doaj   +1 more source

Valsartan in the treatment of heart failure or left ventricular dysfunction after myocardial infarction

, 2007
Naylin Bissessor1, Harvey White21Cardiology Research Fellow, 2Director of Coronary Care and Green Lane, Cardiovascular Research Unit, Green Lane Cardiovascular Research Unit, Auckland City Hospital, Auckland, New ZealandAbstract: The physiological role ...
Naylin Bissessor, Harvey White
core  

BIOAVAILABILITY OF VALSARTAN LIQUID ORAL DOSAGE FORMS

, 2013
The oral bioavailability of valsartan from extemporaneous suspension and solution formulation was evaluated relative to tablet formulation in two separate open label, randomize crossover studies in healthy adults.
Gangadhar Sunkara, Anisha E. Mendonza, Jimmy Flarakos, Neelakantham, Srikanth, Biswal, Shibadas, Zhang, Yiming, Solar-Yohay, Susan, Venkateswar Jarugula, Flarakos, Jimmy, Girish Bende, Susan Solar‐Yohay, Mendonza, Anisha, Srikanth Neelakantham, Robert Wagner, Jarugula, Venkateswar, Yiming Zhang, Bende, Girish, Sunkara, Gangadhar, Wagner, Robert, Shibadas Biswal   +19 more
core   +1 more source

Sacubitril/valsartan Pubmed Search Strategy

, 2020
Sacubitril/valsartan Protocol for Systematic Review - PubMed Search ...
David Byrne (8256927)
core   +1 more source